CRISPR is a gene-editing tool that acts like “molecular scissors,” but using it on cancer is complex. The technology’s biggest impact so far is in research labs, helping scientists understand how ...

Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer. Researchers from Tel Aviv University (Israel), led by Razan Masarwy, have investigated utilizing CRISPR ...

Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, affecting over half a million people each year and causing about 300,000 ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

Immunotherapeutic strategies have made huge strides in cancer treatment for many solid tumors over the past decade. But the promising results have failed to make a large change in the treatment of ...

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

A team of Northwestern investigators has discovered novel molecular underpinnings of a common oncogenic mutation in cancer, ...

Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form—but instead of fueling ...

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.